Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclorosiswith emphasis upon survival

Amyotrophic Lateral Sclerosis

Volumn 8, Issue 1, 2007, Pages 36-41

  Vender, Robert ^a   Mauger, David ^b   Walsh, Susan ^c   Alam, Shoaib ^a   Simmons, Zachary ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c ALS Association   (United States)

Author keywords

Amyotrophic lateral sclerosis; Predictors of survival; Respiratory system abnormalities

Indexed keywords

ACUTE RESPIRATORY FAILURE; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DEATH; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DISEASE COURSE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFECTIOUS PNEUMONIA; INFORMATION RETRIEVAL; LONGITUDINAL STUDY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TRACHEOSTOMY; UNITED STATES; VENOUS THROMBOEMBOLISM;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY; RESPIRATORY SYSTEM ABNORMALITIES; SURVIVAL ANALYSIS;

EID: 33847270566     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/17482960600863951     Document Type: Article

References (33)

1. Rowland, L. P. and Shneider, N. A. (2001) Amyotrophic lateral sclerosis. N Engl J Med, 344, pp. 1688-1701.
2. World Medical Association Declaration of Helsinki (1997) Recommendations guiding physicians in biomedical research involving human subjects. JAMA, 277, pp. 925-926.
3. Brooks, B. R., Miller, R. B., Swash, M. and Munsat, T. L. (2000) For the Worldwide Federation of Neurology research Group on Motor Neuron Disease. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. ALS, 1, pp. 293-299.
4. American Thoracic Society (1995) ATS: Standardization of spirometry; 1994 Update. Am J Respir Crit Care Med, 152, pp. 1107-1136.
5. Knudson, R. J., Lebowitz, M. D., Holberg, J. C. and Burrows, B. (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis, 127, pp. 725-734.
6. Crapo, R. O., Morris, A. H. and Gardner, R. M. (1981) Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis, 123, pp. 859-864.
7. Dawson-Saunders, B. and Trapp, R. G. (1990) Basic and clinical biostatistics, Norwalk, CT, Appleton & Lange
8. Lee, J. R-J., Annegers, J. F. and Appel, S. H. (1995) Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci, 132, pp. 207-215.
9. Chio, A., Mora, G., Leone, M., Mazzini, L., Cocito, D. and Giordana, M. T. (2002) Early symptom progression rate is related to ALS outcome: A prospective population-based study. Neurology, 59, pp. 99-103.
10. Aquila, M. A. del, Longstreth, W. T., McGuire, V., Koepsell, T. D. and van Belle, G. (2003) Prognosis in amyotrophic lateral sclerosis: A population based study. Neurology, 60, pp. 813-819.
11. Miller, R. G., Rosenberg, J. A., Gelinas, D. F., Mitsumoto, H., Newman, D. and Sufit, R. (1999) The ALS Practice Parameters Task Force. Neurology, 52, pp. 1311-1323.
12. Armon, C. and Moses, D. (1998) Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci, 160, p. S37.
13. Armon, C., Graves, M. C., Moses, D., Forte, D. K., Sepulveda, L., Darby, S. M. and Smith, R. A. (2000) Linear estimates of disease progression predict survival in patients with amyotrophic lateral sclerosis. Muscle Nerve, 23, pp. 874-882.
14. Kaufmann, P., Levy, G., Thompson, J., Delbene, M. L., Battista, V. and Gordon, P. H. (2005) The ALSFRS-R predicts survival time in an ALS clinic population. Neurology, 64, pp. 38-43.
15. Stambler, N., Charatan, M., Cedarbaum, J. and ALS CNTF Treatment Study Group (1998) Prognostic indicators of survival in ALS. Neurology, 50, pp. 66-72.
16. Magnus, T., Beck, M. Giess, R., Puls, I., Naumann, M. and Toyka, K. V. (2002) Disease progression in amyotrophic lateral sclerosis: Predictors of survival. Muscle Nerve, 25, pp. 709-714.
17. Schmidt, E. P., Drachman, D. B., Wiener, C. M., Clawson, L., Kimball, R. and Lechtzin, N. (2005) Pulmonary predictors of survival in amyotrophic lateral sclerosis: Use in clinical trial design. Muscle Nerve
18. Czaplinski, A., Yen, A. A. and Appel, S. H. (2006) Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population. J Neurol Neurosurg Psych, 77, pp. 390-392.
19. Schiffman, P. L. and Belsh, J. M. (1993) Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Chest, 103, pp. 508-513.
20. Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M. and Melton, J. L. (1999) Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med, 159, pp. 445-453.
21. Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M. and Melton, L. J. (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism. Arch Intern Med, 158, pp. 585-593.
22. Heit, J. A., Melton, J. L. J., Lohse, C. M., Petterson, T. M., Silverstein, M. D., Mohr, D. N. and O'Fallon, W. M. (2001) Incidence of venous thromboembolism in hospitalized vs. community residents. Mayo Clin Proc, 76, pp. 1102-1111.
23. Cushman, M., Tsai, A. W., White, R. H., Heckbert, S. R., Rosamond, W. D., Enright, P. and Folsom, A. R. (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med, 117, pp. 19-25.
24. Geerst, W. H., Pineo, G. F. Heit, J. A., Berqvist, D., Lassen, M. R., Colwell, C. W. and Ray, J. G. (2004) Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, p. S338.
25. Elman, L. B., Siderowf, A., Houseman, G., Kelley, M. and McCluskey, L. F. (2005) Venous thrombosis in an ALS population over four years. Amyotrophic Lateral Sclerosis, 6, pp. 246-249.
26. Chastre, J. and Fagon, J-V. (2002) State of the Art: Ventilator Associated Pneumonia. Am J Respir Crit Care Med, 165, pp. 867-903.
27. Kollef, M. H. (2004) Prevention of hospital-associated and ventilator-associated pneumonia. Crit Care Med, 32, pp. 1396-1405.
28. American Thoracic Society (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and health care-associated pneumonia. Am J Respir Crit Care Med, 171, pp. 388-416.
29. de Carvalho, M., Costa, J. and Swash, M. (2005) Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotrophic Lateral Sclerosis, 6, pp. 202-212.
30. Traynor, B. J., Alexander, M., Corr, B. Frost, E. and Hardiman, O. (2003) An outcome study of riluzole in amyotrophic lateral sclerosis. J Neurol, 250, pp. 473-479.
31. Morgan, R. K., McNally, S., Alexander, M., Conroy, R., Hardiman, O. and Costello, R. W. (2005) Use of sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis. Am J Respir Crit Care Med, 171, pp. 269-274.
32. Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., Nakanishi, A. and BDNF ALS Group (Phase III) (1999) The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci, 169, pp. 13-21.
33. Mustfa, N., Walsh, E. Bryant, V., Lyall, R. J., Addington-Hall, J. and Goldstein, L. H. (2006) The effect of non-invasive ventilation on ALS patients and their care givers. Neurol, 66, pp. 1211-1217.